Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa [Phase 3]
A Phase 3 clinical trial evaluating Oleogel-S10 for Epidermolysis Bullosa has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa [Phase 2]
Phase 2 clinical trial of INM-755 (cannabinol) cream for epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa [Phase 2]
Phase 2 trial investigating a neurokinin-1 receptor antagonist for pruritus in Epidermolysis Bullosa has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Phase 3]
Phase 3 open-label trial of EB-101 for recessive dystrophic epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Topical Gentamicin Nonsense Suppression Therapy of EB [Phase 1, Phase 2]
A combined Phase 1/2 trial investigating topical gentamicin as a nonsense suppression therapy for Epidermolysis Bullosa has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. [Phase 2]
A Phase 2 dose-ranging study evaluating Dentoxol Mouthrinse for oral symptoms in Epidermolysis Bullosa with oral ulcers; status currently un…
-
CLINICAL_TRIALS withdrawal · 2021-06-18Clinical Trial Update: The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial [Phase 2, Phase 3]
A Phase II/III trial evaluating 3% cannabidiol (CBD) cream for Epidermolysis Bullosa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-10-28Clinical Trial Update: Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa [Phase 4]
A Phase 4 clinical trial evaluating tetracycline for Epidermolysis Bullosa has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex [Phase 2]
Phase 2 long-term open-label study evaluating the safety of diacerein 1% ointment topical formulation in epidermolysis bullosa simplex.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) [Phase 1]
Phase 1 pharmacokinetic study evaluating diacerein and rhein after maximum use in patients with epidermolysis bullosa, completed with result…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa [Phase 2]
Phase 2 trial update on SD-101 for Epidermolysis Bullosa has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa [Phase 2]
Open-label extension study assessing safety of SD-101 cream in Epidermolysis Bullosa; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa [Phase 3]
Open-label extension study assessing long-term safety of Zorblisa (SD-101-6.0) in Epidermolysis Bullosa; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa [Phase 2]
Phase 2 trial update evaluating a chimeric skin product in patients with epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients [Phase 2]
Phase 2 trial update for a neurokinin-1 receptor antagonist addressing itch in epidermolysis bullosa patients; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa [Phase 3]
Phase 3 trial updates for SD-101 cream in Epidermolysis Bullosa have been completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa [Phase 2]
A Phase 2 trial evaluating the efficacy of trimethoprim for wound healing in patients with Epidermolysis Bullosa has completed. The update s…
-
CLINICAL_TRIALS research · 2017-08-24Clinical Trial Update: Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa
This completed clinical trial update describes a survey designed to identify burdens and unmet needs of patients with Epidermolysis Bullosa.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care [NA]
A completed clinical trial compared Helicoll collagen dressings with standard of care for treating wounds in patients with epidermolysis bul…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa [Phase 1]
Phase I trial evaluating isotretinoin in patients with recessive dystrophic epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa [Phase 4]
An observational Phase 4 trial evaluating Apligraf for nonhealing wounds in patients with Epidermolysis Bullosa has been terminated.
-
CLINICAL_TRIALS withdrawal · 2014-04-11Clinical Trial Update: Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes [NA]
The clinical trial evaluating grafting of Epidermolysis Bullosa wounds with cultured revertant autologous keratinocytes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing [Phase 3]
A Phase 3 trial evaluating ABH001 for non-healing wounds in epidermolysis bullosa has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa [Phase 1]
Phase 1 clinical trial assessing autologous transplantation of cultured fibroblasts on an amniotic membrane in patients with Epidermolysis b…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa [Phase 2]
Phase 2 trial evaluating thymosin beta-4 for wound healing in epidermolysis bullosa was terminated; results were posted in 2013.